| 英文名称 | 中文名称 | CAS | MF |
|
Acetamide, 2-ethoxy-N-(4-pyridinylmethyl)- (9CI)
|
|
600140-46-3
|
C10H14N2O2
|
|
3-Piperidinecarboxylicacid,1-(ethoxyacetyl)-,ethylester(9CI)
|
|
600140-66-7
|
C12H21NO4
|
|
4-Piperidinecarboxylicacid,1-(ethoxyacetyl)-,methylester(9CI)
|
|
600140-68-9
|
C11H19NO4
|
|
Piperazine,1-(ethoxyacetyl)-4-ethyl-
|
|
600140-82-7
|
C10H20N2O2
|
|
Piperidine, 1-(1-oxo-2-phenoxybutyl)- (9CI)
|
|
600141-58-0
|
C15H21NO2
|
|
O-(2-(Boc-amino)-ethyl)-O-(2-(diglycolyl-amino)ethyl)EG6
|
BOC-PEG-酸(聚合度为 7)
|
600141-83-1
|
C25H48N2O13
|
|
Oxaziridine, 3,3-dimethyl-2-(trifluoroacetyl)- (9CI)
|
|
600146-00-7
|
C5H6F3NO2
|
|
2-(4-chlorophenoxy)-N-[5-(3,4-dimethoxybenzyl)-1,3,4-thiadiazol-2-yl]acetamide
|
|
600149-76-6
|
C19H18ClN3O4S
|
|
N-[5-(3,4-dimethoxybenzyl)-1,3,4-thiadiazol-2-yl]-2-(phenylsulfanyl)acetamide
|
|
600150-43-4
|
C19H19N3O3S2
|
|
Fmoc-Dpr(Boc-Aoa)-OH
|
NΑ-FMOC-NΒ-(N-BOC-氨基氧基乙酰基)-L-2,3-二氨基丙酸
|
600153-12-6
|
C25H29N3O8
|
|
Acetamide, N-ethyl-N-(5-methyl-4-isoxazolyl)- (9CI)
|
|
600153-32-0
|
C8H12N2O2
|
|
3-Amino-3,4-dihydro-1,5-naphthyridin-2(1H)-one
|
3-氨基-3,4-二氢-1,5-萘啶-2(1H)-酮
|
600157-67-3
|
C8H9N3O
|
|
2-Furanamine, N,N,3-triphenyl-5-(phenylsulfinyl)-4-(trifluoromethyl)-
|
|
600158-16-5
|
C29H20F3NO2S
|
|
2-Furancarboxamide,tetrahydro-N-methyl-(9CI)
|
Tetrahydro-N-methyl-2-furancarboxamide
|
600159-39-5
|
C6H11NO2
|
|
2-Furancarboxamide,N-(5-chloro-2-pyridinyl)tetrahydro-(9CI)
|
N-(5-Chloro-2-pyridinyl)tetrahydro-2-furancarboxamide
|
600159-40-8
|
C10H11ClN2O2
|
|
2-Furancarboxamide,tetrahydro-N-(1-methylethyl)-(9CI)
|
Tetrahydro-N-(1-methylethyl)-2-furancarboxamide
|
600159-42-0
|
C8H15NO2
|
|
2-Furancarboxamide,tetrahydro-N-(3-pyridinylmethyl)-(9CI)
|
|
600159-47-5
|
C11H14N2O2
|
|
2-Furancarboxamide,N-(cyanomethyl)tetrahydro-(9CI)
|
|
600159-49-7
|
C7H10N2O2
|
|
2-Furancarboxamide,N-[3-(acetylamino)phenyl]tetrahydro-(9CI)
|
|
600159-60-2
|
C13H16N2O3
|
|
2-Furancarboxamide,N-(2-fluoro-5-nitrophenyl)tetrahydro-(9CI)
|
|
600159-61-3
|
C11H11FN2O4
|
|
2-Furancarboxamide,tetrahydro-N-2-pyridinyl-(9CI)
|
Tetrahydro-N-2-pyridinyl-2-furancarboxamide
|
600159-64-6
|
C10H12N2O2
|
|
2-Furancarboxamide,tetrahydro-N,N-dimethyl-(9CI)
|
Tetrahydro-N,N-dimethyl-2-furancarboxamide
|
600159-66-8
|
C7H13NO2
|
|
2-Furancarboxamide,N-[4-(acetylamino)phenyl]tetrahydro-(9CI)
|
|
600159-70-4
|
C13H16N2O3
|
|
2-Furancarboxamide,tetrahydro-N-(2-methyl-3-nitrophenyl)-(9CI)
|
|
600159-75-9
|
C12H14N2O4
|
|
4-Piperidinecarboxylicacid,1-[(tetrahydro-2-furanyl)carbonyl]-,methylester(9CI)
|
|
600159-85-1
|
C12H19NO4
|
|
2-Furancarboxamide,tetrahydro-N-[2-(1-methylpropyl)phenyl]-(9CI)
|
|
600159-92-0
|
C15H21NO2
|
|
2-Furancarboxamide,N-[5-(1,1-dimethylethyl)-1,3,4-thiadiazol-2-yl]tetrahydro-
|
|
600159-96-4
|
C11H17N3O2S
|
|
2-Furancarboxamide,tetrahydro-N-[5-(2-methylpropyl)-1,3,4-thiadiazol-2-yl]-
|
|
600160-03-0
|
C11H17N3O2S
|
|
2-Furancarboxamide,tetrahydro-N-(4,5,6,7-tetrahydro-2-benzothiazolyl)-(9CI)
|
|
600160-04-1
|
C12H16N2O2S
|
|
3,4-dioxobutanoic acid ethyl ester
|
|
600160-23-4
|
C6H8O4
|
|
3,4-dichloro-N-[5-(3,4-dimethoxybenzyl)-1,3,4-thiadiazol-2-yl]benzamide
|
|
600163-19-7
|
C18H15Cl2N3O3S
|
|
4-[2-(TriMethylsilyl)ethynyl]pyrene
|
4-[2-(TriMethylsilyl)ethynyl]pyrene
|
600168-40-9
|
C21H18Si
|
|
H-Thr-Ser-Gly-Pro-Leu-Gly-Asn-Leu-Ala-Glu-Glu-Leu-Asn-Gly-Tyr-Ser-Arg-Lys-Lys-Gly-Gly-Phe-Ser-Phe-Arg-Phe-NH2
|
ORPHAN GPCR SP9155 AGONIST P518 (HUMAN)
|
600171-68-4
|
C127H195N37O37
|
|
H-Ala-Ser-Gly-Pro-Leu-Gly-Thr-Leu-Ala-Glu-Glu-Leu-Ser-Ser-Tyr-Ser-Arg-Arg-Lys-Gly-Gly-Phe-Ser-Phe-Arg-Phe-NH2
|
ORPHAN GPCR SP9155 AGONIST P550 (MOUSE)
|
600171-70-8
|
C126H195N37O37
|
|
2,7,12-tribromo-5,5',10,10',15,15'-hexahexyltruxene
|
2,7,12-三溴-5,5',10,10',15,15'-六己基三聚茚
|
600172-86-9
|
C63H87Br3
|
|
2,2',2''-(5,5,10,10,15,15-hexahexyl-10,15-dihydro-5H -diindeno[1,2-a:1',2'-c]fluorene-2,7,12-triyl)trithiophene
|
2,2',2''-(5,5,10,10,15,15-hexahexyl-10,15-dihydro-5H -diindeno[1,2-a:1',2'-c]fluorene-2,7,12-triyl)trithiophene
|
600172-87-0
|
C75H96S3
|
|
4-Benzofuranol, 2,3-dihydro-5-methyl- (9CI)
|
|
600176-61-2
|
C9H10O2
|
|
Thiocyanic acid, 2,3-dihydro-7-hydroxy-1H-inden-4-yl ester (9CI)
|
|
600176-67-8
|
C10H9NOS
|
|
rac trans-Hydroxy Glimepiride-D5
|
反式羟基格列美脲
|
600177-94-4
|
C24H34N4O6S
|
|
1-(2-nitrophenyl)indoline-2-carboxylic acid
|
1-(2-NITROPHENYL)INDOLINE-2-CARBOXYLIC ACID
|
600179-43-9
|
C15H12N2O4
|
|
2,5-Cyclohexadiene-1-carboxylicacid,1,4-dimethyl-(9CI)
|
|
600273-43-6
|
C9H12O2
|
|
Propanamide, N-ethyl-N-(5-methyl-4-isoxazolyl)-
|
|
600638-64-0
|
C9H14N2O2
|
|
Ethanone, 1-(1,2-diethyl-1H-imidazol-5-yl)- (9CI)
|
|
600638-65-1
|
C9H14N2O
|
|
Ethanone, 1-(2-cyclopropyl-1-methyl-1H-imidazol-5-yl)- (9CI)
|
|
600638-77-5
|
C9H12N2O
|
|
Acetamide, N-(5-methyl-4-isoxazolyl)-N-propyl-
|
|
600638-84-4
|
C9H14N2O2
|
|
1-(2-Methyl-3-propyl-3H-imidazol-4-yl)-ethanone
|
|
600638-85-5
|
C9H14N2O
|
|
1-(3-Isopropyl-3H-imidazol-4-yl)-ethanone
|
|
600638-86-6
|
C8H12N2O
|
|
4-Isoxazolamine,5-methyl-N-propyl-(9CI)
|
|
600638-87-7
|
C7H12N2O
|
|
Formamide, N-(5-methyl-4-isoxazolyl)-N-propyl- (9CI)
|
|
600638-88-8
|
C8H12N2O2
|
|
1-(3-Propyl-3H-imidazol-4-yl)-ethanone
|
|
600638-89-9
|
C8H12N2O
|
|
2-Propen-1-one,1-(1,2-diethyl-1H-imidazol-5-yl)-3-(dimethylamino)-(9CI)
|
|
600638-92-4
|
C12H19N3O
|
|
Ethanone, 1-[2-(methoxymethyl)-1-methyl-1H-imidazol-5-yl]- (9CI)
|
|
600639-54-1
|
C8H12N2O2
|
|
Formamide, N-(1-methylethyl)-N-(5-methyl-4-isoxazolyl)- (9CI)
|
|
600639-55-2
|
C8H12N2O2
|
|
Benzo[b]thiophene-2-carboxamide, 3-chloro-N-[4-[(diethylamino)sulfonyl]phenyl]- (9CI)
|
|
600640-87-7
|
C19H19ClN2O3S2
|
|
Benzo[b]thiophene-2-carboxamide, 3-chloro-N-[4-[(hexylamino)sulfonyl]phenyl]- (9CI)
|
|
600640-88-8
|
C21H23ClN2O3S2
|
|
Benzo[b]thiophene-2-carboxamide, 3-chloro-N-[4-[[(1-methylpropyl)amino]sulfonyl]phenyl]- (9CI)
|
|
600640-89-9
|
C19H19ClN2O3S2
|
|
Benzo[b]thiophene-2-carboxamide, 3-chloro-N-[5-[(4-chlorophenoxy)methyl]-1,3,4-thiadiazol-2-yl]- (9CI)
|
|
600640-90-2
|
C18H11Cl2N3O2S2
|
|
Benzo[b]thiophene-2-carboxamide, 3-chloro-N-[5-[(3,4-dimethoxyphenyl)methyl]-1,3,4-thiadiazol-2-yl]- (9CI)
|
|
600640-91-3
|
C20H16ClN3O3S2
|
|
Benzo[b]thiophene-2-carboxamide, 3-chloro-N-[5-(phenylmethyl)-1,3,4-thiadiazol-2-yl]- (9CI)
|
|
600640-92-4
|
C18H12ClN3OS2
|
|
Benzo[b]thiophene-2-carboxamide, 3-chloro-N-[5-(1-ethylpropyl)-1,3,4-thiadiazol-2-yl]- (9CI)
|
|
600640-93-5
|
C16H16ClN3OS2
|
|
6-Isoquinolinol,1,2,3,4-tetrahydro-1-(2-thienyl)-(9CI)
|
|
600646-68-2
|
C13H13NOS
|
|
6-Isoquinolinol,1,2,3,4-tetrahydro-1-(5-methyl-2-thienyl)-(9CI)
|
|
600646-85-3
|
C14H15NOS
|
|
6-Isoquinolinol,1,2,3,4-tetrahydro-1-(3-methyl-2-thienyl)-(9CI)
|
|
600647-35-6
|
C14H15NOS
|
|
Isoquinoline, 1,2,3,4-tetrahydro-6-methoxy-1-(4-pyridinyl)- (9CI)
|
|
600647-43-6
|
C15H16N2O
|
|
6-Isoquinolinol,1,2,3,4-tetrahydro-1-(4-pyridinyl)-(9CI)
|
|
600647-50-5
|
C14H14N2O
|
|
6-Isoquinolinol,1,2,3,4-tetrahydro-1-(3-methyl-4-pyridinyl)-(9CI)
|
|
600647-67-4
|
C15H16N2O
|
|
6,7-Isoquinolinediol,1,2,3,4-tetrahydro-1-(2-pyridinyl)-(9CI)
|
|
600647-73-2
|
C14H14N2O2
|
|
Isoquinoline, 1,2,3,4-tetrahydro-6-methoxy-1-(2-pyridinyl)- (9CI)
|
|
600647-76-5
|
C15H16N2O
|
|
6-Isoquinolinol,1,2,3,4-tetrahydro-1-(2-pyridinyl)-(9CI)
|
|
600647-83-4
|
C14H14N2O
|
|
6-Isoquinolinol,1,2,3,4-tetrahydro-1-(6-methyl-2-pyridinyl)-(9CI)
|
|
600648-00-8
|
C15H16N2O
|
|
2-Cyclopenten-1-one, 4-methyl-5-(2-methylpropylidene)-, (4S,5E)- (9CI)
|
|
600684-12-6
|
C10H14O
|
|
Ethanone, 2-(ethylthio)-2,2-difluoro-1-phenyl- (9CI)
|
|
600689-94-9
|
C10H10F2OS
|
|
2-Piperidinemethanol,5-amino-,(2R,5R)-rel-(9CI)
|
|
600698-43-9
|
C6H14N2O
|
|
4-Isoxazolamine,N-cyclobutyl-5-methyl-(9CI)
|
|
600699-32-9
|
C8H12N2O
|
|
4-Isoxazolamine,N-(2-methoxy-1-methylethyl)-5-methyl-(9CI)
|
|
600699-35-2
|
C8H14N2O2
|
|
Cyclopropanecarboxamide, N-(5-methyl-4-isoxazolyl)- (9CI)
|
|
600699-38-5
|
C8H10N2O2
|
|
4-Isoxazolamine,N-(cyclopropylmethyl)-5-methyl-(9CI)
|
|
600699-39-6
|
C8H12N2O
|
|
Ethanone, 1-(1-cyclopropyl-2-methyl-1H-imidazol-5-yl)- (9CI)
|
|
600699-44-3
|
C9H12N2O
|
|
4-Isoxazolamine,N-cyclopentyl-5-methyl-(9CI)
|
|
600699-45-4
|
C9H14N2O
|
|
Ethanone, 1-(1-cyclopentyl-2-methyl-1H-imidazol-5-yl)- (9CI)
|
|
600699-47-6
|
C11H16N2O
|
|
4-Isoxazolamine,5-methyl-N-(tetrahydro-3-furanyl)-(9CI)
|
|
600699-48-7
|
C8H12N2O2
|
|
4-Isoxazolamine,N-(1-cyclopropylethyl)-5-methyl-(9CI)
|
|
600699-53-4
|
C9H14N2O
|
|
Ethanone, 1-[2-ethyl-1-(2-methoxy-1-methylethyl)-1H-imidazol-5-yl]- (9CI)
|
|
600699-63-6
|
C11H18N2O2
|
|
Cyclopenta[c]pyran-3(1H)-one, hexahydro-6-methoxy-, (4aR,6R,7aR)-rel- (9CI)
|
|
600700-65-0
|
C9H14O3
|
|
Cyclopenta[c]pyran-3(1H)-one, hexahydro-6-methoxy-, (4aR,6S,7aR)-rel- (9CI)
|
|
600700-66-1
|
C9H14O3
|
|
Cyclopenta[c]pyran-3(1H)-one, hexahydro-6-methylene-, (4aR,7aR)-rel- (9CI)
|
|
600700-71-8
|
C9H12O2
|
|
5-Thiazolecarboxylicacid,4-ethyl-2-(ethylamino)-(9CI)
|
5-THIAZOLECARBOXYLICACID,4-ETHYL-2-(ETHYLAMINO)-
|
600707-16-2
|
C8H12N2O2S
|
|
D-manno-Octonic acid, 3,7-anhydro-2-deoxy-, (3xi-iota)- (9CI)
|
|
600708-94-9
|
C8H14O7
|
|
N-[1-(4-hydroxy)butyl]indole-2-carboxamide
|
N-[1-(4-HYDROXY)BUTYL]INDOLE-2-CARBOXAMIDE
|
600709-74-8
|
C13H16N2O2
|
|
Benzeneacetonitrile, 2-amino-5-fluoro- (9CI)
|
2-(2-氨基-5-氟苯基)乙腈
|
600710-17-6
|
C8H7FN2
|
|
1H-Indol-2-amine,5-fluoro-(9CI)
|
|
600710-18-7
|
C8H7FN2
|
|
Benzeneacetic acid, alpha-cyano-2-ethyl-, ethyl ester (9CI)
|
158643
|
600716-78-7
|
C13H15NO2
|
|
N1-(3-(Dimethylamino)propyl)-5-fluorobenzene-1,2-diamine
|
|
600725-18-6
|
C11H18FN3
|
|
4-[(2-AMino-phenylaMino)-Methyl]-piperidine-1-carboxylic acid tert-butyl ester
|
4-[(2-氨基-苯基氨基)-甲基]-哌啶-1-羧酸叔丁基酯
|
600725-25-5
|
C17H27N3O2
|
|
Phenylalanine, 3,4-diethyl- (9CI)
|
|
600725-38-0
|
C13H19NO2
|
|
(4-Amino-3-chloro-5-(trifluoromethyl)phenyl)methanol(WXG00387)
|
(4-氨基-3-氯-5-(三氟甲基)苯基)甲醇
|
600725-44-8
|
C8H7ClF3NO
|
|
N1-cyclopentylbenzene-1,2-diamine
|
N1-环戊基苯-1,2-二胺
|
600725-69-7
|
C11H16N2
|
|
AcetaMide-13C2
|
AcetaMide-13C2
|
600726-26-9
|
C2H5NO
|
|
Cyclohexanecarboxaldehyde, 2-hydroxy-3,3-dimethyl-, (1S,2R)- (9CI)
|
|
600726-40-7
|
C9H16O2
|
|
Cyclohexanecarboxaldehyde, 2-hydroxy-5,5-dimethyl-, (1S,2S)- (9CI)
|
|
600726-41-8
|
C9H16O2
|